ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Registrieren

Bereits Mitglied? Einloggen

Pepperstone

Jetzt Handeln

Pepperstone
Marktdaten
News
Werkzeuge
Märkte
Entdecken

Hot Features

Follow Feed

Vernetzen Sie sich mit Händlern und Investoren in unserer Follow-Feed-Community.

Optionen-Flow

Erkunden Sie umfassende Optionsdaten und nutzen Sie erweiterte Filter mit Options Flow.

Watchlist

Organisieren und überwachen Sie Ihre Aktien- und Vermögensbeobachtungsliste mit dem Monitor.
Anmelden Premium IconPremium Help Menu
DAX
21.411,53
0,72%
S&P 500
6.118,71
0,53%
Dow Jones
44.565,07
0,92%
Euro vs US Dollar
1,0458
0,41%
Bitcoin
104.764,44
0,77%
Pepperstone
Advertisement
Registration Strip Icon for monitor Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Registrieren
  1. Startseite
  2. Investieren
  3. Aktien
  4. USA
  5. NASDAQ

  6. Verona Pharma Plc (VRNA) Börsenkurse

Verona Pharma Plc

Verona Pharma Plc (VRNA)

NASDAQ
54,08
-0,59
(-1,08%)
Geschlossen 24 Januar 10:00PM
Verzögert um 15 Minuten
54,08
-0,08
(-0,15%)
Nach Börsenschluss: 11:47PM
Verzögert um 15 Minuten

Echtzeit-Diskussionen und Handelsideen: Handeln Sie mit Zuversicht mit unserer leistungsstarken Plattform.

Premium

Wichtige Statistiken und Details

Current Price
54,08
Gebot
54,08
Fragen
55,00
Volumen
874.851
53,815 Tagesbereich 55,03
0,00 52-Wochen-Bereich 0,00
Marktkapitalisierung
4,425B
Handelsende
54,67
Handelsbeginn
54,49
Letzte Trade
1
@
54.99
Letzter Handelszeitpunkt
Finanzvolumen
US$ 47.708.663
VWAP
54,5335
Durchschnittliches Volumen (3 Mio.)
-
Ausgegebene Aktien
81.831.170
Dividendenrendite
-
Kurs-Gewinn-Verhältnis
0,00
Gewinn pro Aktie (EPS)
-
Erlöse
-
Nettogewinn
-54,37M

Über Verona Pharma Plc

Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which ... Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative therapeutics for the treatment of respiratory diseases with significant unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma. Mehr anzeigen

Sektor
Pharmaceutical Preparations
Branche
Pharmaceutical Preparations
Website
www.veronapharma.com
Hauptsitz
London, Gbr
Gegründet
-
Verona Pharma Plc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker VRNA. The last closing price for Verona Pharma was US$54,67. Over the last year, Verona Pharma shares have traded in a share price range of US$ 0,00 to US$ 0,00.

Verona Pharma currently has 81.831.170 shares in issue. The market capitalisation of Verona Pharma is US$4,47 billion.

Option-Flow Verona Pharma (VRNA)

Vollständigen Option-Flow anzeigen

Gesamtfluss

Bullisch

Nettoprämie

140k

Calls / Puts

175,00%

Käuf. / Verkä.

57,14%

OTM / ITM

10,00%

Sweeps

0,00%

VRNA Neueste Nachrichten

Weitere Nachrichten

Form 8-K - Current report

07 Januar 2025
Edgar (US Regulatory)

Verona Pharma Reports Strong Ohtuvayre™ Launch and Provides Preliminary Fourth Quarter and Full Year 2024 Financial Highlights

Approximately $36 million and $42 million net product sales of Ohtuvayre for the fourth quarter and full year 2024, respectively More than 3,500 unique prescribers and over 16,000 prescriptions...

07 Januar 2025
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

27 November 2024
Edgar (US Regulatory)

Form 144 - Report of proposed sale of securities

25 November 2024
Edgar (US Regulatory)

Verona Pharma Announces December 2024 Investor Conference Participation

LONDON and RALEIGH, N.C., Nov. 19, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company overview...

19 November 2024
GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

14 November 2024
Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities

08 November 2024
Edgar (US Regulatory)

Verona Pharma to Present at Jefferies London Healthcare Conference

LONDON and RALEIGH, N.C., Nov. 05, 2024 (GLOBE NEWSWIRE) -- Verona Pharma plc (Nasdaq: VRNA) (“Verona Pharma” or the “Company”) announces that senior management will present a company overview...

05 November 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

04 November 2024
Edgar (US Regulatory)

Form 8-K - Current report

04 November 2024
Edgar (US Regulatory)
Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10000000DR
40000000DR
120000000DR
260000000DR
520000000DR
1560000000DR
2600000000DR

VRNA - Frequently Asked Questions (FAQ)

What is the current Verona Pharma share price?
The current share price of Verona Pharma is US$ 54,08
How many Verona Pharma shares are in issue?
Verona Pharma has 81.831.170 shares in issue
What is the market cap of Verona Pharma?
The market capitalisation of Verona Pharma is USD 4,47B
What is the 1 year trading range for Verona Pharma share price?
Verona Pharma has traded in the range of US$ 0,00 to US$ 0,00 during the past year
What is the reporting currency for Verona Pharma?
Verona Pharma reports financial results in USD
What is the latest annual profit for Verona Pharma?
The latest annual profit of Verona Pharma is USD -54,37M
What is the registered address of Verona Pharma?
The registered address for Verona Pharma is ONE CENTRAL SQUARE, CARDIFF, LONDON, CF10 1FS
What is the Verona Pharma website address?
The website address for Verona Pharma is www.veronapharma.com
Which industry sector does Verona Pharma operate in?
Verona Pharma operates in the PHARMACEUTICAL PREPARATIONS sector

Beweger

Alle Anzeigen
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
DWTXDogwood Therapeutics Inc
US$ 13,2484
(373,16%)
103,21M
DGNXDiginex Ltd
US$ 12,75
(70,00%)
9,74M
RNAZTransCode Therapeutics Inc
US$ 5,61
(60,74%)
10,9M
EVAXEvaxion Biotech AS
US$ 3,76
(57,98%)
4,02M
MCTRCTRL Group Ltd
US$ 6,77
(56,35%)
8,84M
CHSNChanson International Holding
US$ 0,83352
(-86,77%)
21,85M
ICONIcon Energy Corporation
US$ 0,5348
(-59,18%)
15,88M
JUNSJupiter Neurosciences Inc
US$ 1,50
(-58,10%)
11,08M
BACKIMAC Holdings Inc
US$ 0,78
(-42,01%)
479,52k
DXSTDecent Holding Inc
US$ 2,50
(-38,42%)
11,55M
HEPAHepion Pharmaceuticals Inc
US$ 0,203
(50,37%)
538,53M
NVDANVIDIA Corporation
US$ 147,22
(0,10%)
155,51M
TNXPTonix Pharmaceuticals Holding Corporation
US$ 0,33095
(3,75%)
153,25M
RIMEAlgorhythm Holdings Inc
US$ 0,0338
(1,81%)
137,59M
RGTIRigetti Computing Inc
US$ 13,465
(-3,20%)
133,14M

Foren

Foren anzeigen
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

NASDAQ
VRNA
Verona Pharma
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Deutschland
Unternehmen
Geschäft
Popular
App herunterladen
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

© 2025 ADVFN PLC - Alle Rechte vorbehalten